Cipher Pharmaceuticals Inc (CPH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,511 | 1,925 | 292 | 289 | 273 |
| Income taxes - deferred | -6,252 | 43 | -480 | -1,955 | 1,319 |
| Accounts receivable | -645 | -9,439 | 4,657 | -3,345 | 1,613 |
| Accounts payable and accrued liabilities | 409 | 1,199 | -1,833 | 1,502 | -2,471 |
| Other Working Capital | 8,068 | -248 | 2,828 | -1,695 | -6,279 |
| Other Operating Activity | 5,794 | 8,522 | 761 | 7,638 | 7,961 |
| Operating Cash Flow | $8,885 | $2,002 | $6,225 | $2,434 | $2,416 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -20 | -11 | -6 | -21 |
| Other Investing Activity | 0 | -80,000 | 0 | 0 | -123 |
| Investing Cash Flow | $-7 | $-80,020 | $-11 | $-6 | $-144 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -84 | -29 | -28 | N/A |
| Common Stock Repurchased | 0 | 0 | 0 | -176 | -5,101 |
| Other Financing Activity | -104 | 39,590 | 24 | 103 | 160 |
| Financing Cash Flow | $-104 | $39,506 | $-5 | $-101 | $-4,941 |
| Exchange Rate Effect | -461 | 52 | -206 | -171 | 408 |
| Beginning Cash Position | 9,524 | 47,984 | 41,981 | 39,825 | 42,086 |
| End Cash Position | 17,837 | 9,524 | 47,984 | 41,981 | 39,825 |
| Net Cash Flow | $8,774 | $-38,512 | $6,209 | $2,327 | $-2,669 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,885 | 2,002 | 6,225 | 2,434 | 2,416 |
| Capital Expenditure | -7 | -20 | -11 | -6 | N/A |
| Free Cash Flow | 8,878 | 1,982 | 6,214 | 2,428 | 2,416 |